COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countriesEng Hooi Tan, Daniel Prieto‐Alhambra, Arani Vivekanantham et al.|Lara D. Veeken|2021Cited by 53
Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDISKristin Kostka, Nicole G. Weiskopf, Hong Zhu et al.|Clinical Epidemiology|2022Cited by 26
Clinical Characterization of Patients Diagnosed with Prostate Cancer and Undergoing Conservative Management: A PIONEER Analysis Based on Big DataGiorgio Gandaglia, James N’Dow, Peter-Paul Willemse et al.|European Urology|2023Cited by 17
Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and BevacizumabCindy X. Cai, Patrick Ryan, Scott L. Zeger et al.|Ophthalmology Retina|2024Cited by 16
Reproducible variability: assessing investigator discordance across 9 research teams attempting to reproduce the same observational studyAnna Ostropolets, Patrick Ryan, Evan Minty et al.|Journal of the American Medical Informatics Association|2023Cited by 12